Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1977 1
1978 1
1988 1
1989 1
1996 1
2003 1
2004 2
2005 1
2006 1
2007 1
2008 2
2009 2
2010 6
2011 3
2013 1
2014 1
2015 1
2016 1
2017 1
2018 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C; DMD Care Considerations Working Group. Bushby K, et al. Lancet Neurol. 2010 Jan;9(1):77-93. doi: 10.1016/S1474-4422(09)70271-6. Epub 2009 Nov 27. Lancet Neurol. 2010. PMID: 19945913 Review.
Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial.
Mah JK, Clemens PR, Guglieri M, Smith EC, Finkel RS, Tulinius M, Nevo Y, Ryan MM, Webster R, Castro D, Kuntz NL, McDonald CM, Damsker JM, Schwartz BD, Mengle-Gaw LJ, Jackowski S, Stimpson G, Ridout DA, Ayyar-Gupta V, Baranello G, Manzur AY, Muntoni F, Gordish-Dressman H, Leinonen M, Ward LM, Hoffman EP, Dang UJ; NorthStar UK Network and CINRG DNHS Investigators. Mah JK, et al. JAMA Netw Open. 2022 Jan 4;5(1):e2144178. doi: 10.1001/jamanetworkopen.2021.44178. JAMA Netw Open. 2022. PMID: 35076703 Free PMC article. Clinical Trial.
Symptomatic dystrophinopathies in female children.
Seemann N, Selby K, McAdam L, Biggar D, Kolski H, Goobie S, Yoon G, Campbell C; Canadian Pediatric Neuromuscular Group. Seemann N, et al. Among authors: biggar d. Neuromuscul Disord. 2011 Mar;21(3):172-7. doi: 10.1016/j.nmd.2010.11.001. Epub 2010 Dec 24. Neuromuscul Disord. 2011. PMID: 21186124
Validation of Accelerometer Prediction Equations in Children with Chronic Disease.
Stephens S, Takken T, Esliger DW, Pullenayegum E, Beyene J, Tremblay M, Schneiderman J, Biggar D, Longmuir P, McCrindle B, Abad A, Ignas D, Van Der Net J, Feldman B. Stephens S, et al. Among authors: biggar d. Pediatr Exerc Sci. 2016 Feb;28(1):117-32. doi: 10.1123/pes.2014-0185. Epub 2015 Jul 1. Pediatr Exerc Sci. 2016. PMID: 26182189 Free article.
Endocrine aspects of Duchenne muscular dystrophy.
Bianchi ML, Biggar D, Bushby K, Rogol AD, Rutter MM, Tseng B. Bianchi ML, et al. Among authors: biggar d. Neuromuscul Disord. 2011 Apr;21(4):298-303. doi: 10.1016/j.nmd.2011.02.006. Epub 2011 Feb 25. Neuromuscul Disord. 2011. PMID: 21353552 No abstract available.
IgE in ataxia-telangiectasia and family members.
Biggar D, Lapointe N, Ishizaka K, Meuwissen H, Good RA, Frommel D. Biggar D, et al. Lancet. 1970 Nov 21;2(7682):1089. doi: 10.1016/s0140-6736(70)90326-0. Lancet. 1970. PMID: 4098387 No abstract available.
The CNDR: collaborating to translate new therapies for Canadians.
Korngut L, Campbell C, Johnston M, Benstead T, Genge A, Mackenzie A, McCormick A, Biggar D, Bourque P, Briemberg H, O'Connell C, Dojeiji S, Dooley J, Grant I, Hogan G, Johnston W, Kalra S, Katzberg HD, Mah JK, McAdam L, McMillan HJ, Melanson M, Selby K, Shoesmith C, Smith G, Venance SL, Wee J; CNDR Investigator Network. Korngut L, et al. Among authors: biggar d. Can J Neurol Sci. 2013 Sep;40(5):698-704. doi: 10.1017/s0317167100014943. Can J Neurol Sci. 2013. PMID: 23968944
28 results